July 05, 2019 Cannabis, M&A and data spur strong gains among small and midcaps The usual story of positive data and clinical failure influencing company stock performance was given added interest in the second quarter with price fixing allegations decimating some shares.
June 05, 2018 Forecasts tell a tale of two continents for biosimilars Despite government rhetoric, the US biosimilar market has failed to live up to expectations so far.
May 26, 2017 Upcoming events – Renal cancer data for Acceleron and Coherus’s biosimilar's date with the FDA
